Stuart Poulton Karyopharm Therapeutics Inc. (KPTI) insider trading activity
Stuart Poulton is EVP, Chief Development Officer of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 320,714 shares of KPTI, which is worth approximately $192,428. The most recent transaction as insider was on Feb 18, 2025, when has been sold 5,914 shares (Common Stock) at a price of $0.63 per share, resulting in proceeds of $3,725. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
321K
1.81%
3M change
95.83%
12M change
Total Value Held
$192,428
Stuart Poulton Transaction History
SP
Stuart Poulton
EVP, Chief Development Officer
Newton, MA